Synthetic biology is an emerging field with many possibilities to improve health, energy, the environment, and our food systems. This one-pager defines and describes what a synthetic biology project could look like.
Alicia L. Johnson, Kirstin R.W. Matthews, Caroline SniderDecember 15, 2023
The COVID-19 pandemic revealed a gap in our ability to track and stop the spread of infectious diseases. With funding from the National Science Foundation, a Rice University research team is engineering bacteria to sustainably and continuously monitor wastewater for viruses.
Alicia L. Johnson, Kirstin R.W. Matthews, Caroline SniderNovember 1, 2023
This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Stem cells have two unique properties that make them an appealing therapeutic tool for regenerative medicine: they can grow indefinitely and can differentiate into a wide variety of cell types, including those that form blood, bones, lungs, skin, and the brain.
As the pandemic persisted across the state, did Texans living in cities have better access to Covid-19 vaccines than those in rural areas? How did race or age factor in? The authors assess the successes and shortfalls of Texas' vaccine distribution strategy, and how to do better next time.
Health policy experts Kirstin Matthews and Rekha Lakshmanan compare the three COVID-19 vaccines now available from Pfizer, Moderna and Johnson & Johnson and, in a separate infographic, provide an overview of Operation Warp Speed.
By Michael W. Deem, Melia E. Bonomo and Kirstin R.W. Matthews
Due to the rapidly mutating influenza virus, a new vaccine is usually developed for each flu season. In this policy brief, the authors discuss the current method used by the Centers for Disease Control and Prevention to develop the flu vaccine and propose the use of mathematical modeling to improve the vaccine's effectiveness.
Michael W. Deem, Melia E. Bonomo, Kirstin R.W. MatthewsOctober 29, 2018
Ambassador Edward P. Djerejian, director of the Baker Institute, makes the case for a comprehensive North American strategy in which the U.S., Mexico and Canada act in concert to become the global superpower of the 21st century.
Ambassador Edward P. Djerejian, director of the Baker Institute, describes the key elements of a coherent strategy for defeating ISIS, incorporating both nearer-term strategies and long-term approaches.
Science, technology, and innovation are vital to America’s economy and workforce, and the competitiveness of U.S. industry. The authors offer five recommendations to ensure the establishment of an effective White House Office of Science and Technology Policy.
Kirstin R.W. Matthews, Kenneth M. Evans, Neal F. LaneDecember 5, 2016